Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Clinical Study Evaluating the Safety and Efficacy of Universal CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases

NCT06983964 is registered in ClinicalTrials.gov with Beijing Boren Hospital as lead sponsor.

NCT NCT06983964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06983964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Clinical Study Evaluating the Safety and Efficacy of Universal CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases
Lead sponsor
Beijing Boren Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 20, 2025
Completion date
September 30, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune disease